Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma.

Jafarnejad M, Sové RJ, Danilova L, Mirando AC, Zhang Y, Yarchoan M, Tran PT, Pandey NB, Fertig EJ, Popel AS.

NPJ Syst Biol Appl. 2019 Aug 16;5:29. doi: 10.1038/s41540-019-0107-2. eCollection 2019.

2.

Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.

Kim J, Lima E Silva R, Shmueli RB, Mirando AC, Tzeng SY, Pandey NB, Ben-Akiva E, Popel AS, Campochiaro PA, Green JJ.

Acta Biomater. 2019 Oct 1;97:451-460. doi: 10.1016/j.actbio.2019.07.054. Epub 2019 Jul 30.

PMID:
31374338
3.

A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.

Mirando AC, Shen J, Silva RLE, Chu Z, Sass NC, Lorenc VE, Green JJ, Campochiaro PA, Popel AS, Pandey NB.

JCI Insight. 2019 Feb 21;4(4). pii: 122043. doi: 10.1172/jci.insight.122043. eCollection 2019 Feb 21.

4.

Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.

Bressler EM, Kim J, Shmueli RB, Mirando AC, Bazzazi H, Lee E, Popel AS, Pandey NB, Green JJ.

J Biomed Mater Res A. 2018 Jun;106(6):1753-1764. doi: 10.1002/jbm.a.36360. Epub 2018 Feb 23.

5.

Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma.

Barbhuiya MA, Mirando AC, Simons BW, Lemtiri-Chlieh G, Green JJ, Popel AS, Pandey NB, Tran PT.

Oncotarget. 2017 Sep 21;8(60):101520-101534. doi: 10.18632/oncotarget.21148. eCollection 2017 Nov 24.

6.

Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.

Silva RLE, Kanan Y, Mirando AC, Kim J, Shmueli RB, Lorenc VE, Fortmann SD, Sciamanna J, Pandey NB, Green JJ, Popel AS, Campochiaro PA.

Sci Transl Med. 2017 Jan 18;9(373). pii: eaai8030. doi: 10.1126/scitranslmed.aai8030.

7.

Gene delivery nanoparticles to modulate angiogenesis.

Kim J, Mirando AC, Popel AS, Green JJ.

Adv Drug Deliv Rev. 2017 Sep 15;119:20-43. doi: 10.1016/j.addr.2016.11.003. Epub 2016 Nov 30. Review.

8.

Assessing the effects of threonyl-tRNA synthetase on angiogenesis-related responses.

Mirando AC, Abdi K, Wo P, Lounsbury KM.

Methods. 2017 Jan 15;113:132-138. doi: 10.1016/j.ymeth.2016.11.007. Epub 2016 Nov 12. Review.

9.

Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor.

Mirando AC, Fang P, Williams TF, Baldor LC, Howe AK, Ebert AM, Wilkinson B, Lounsbury KM, Guo M, Francklyn CS.

Sci Rep. 2015 Aug 14;5:13160. doi: 10.1038/srep13160.

10.

Regulation of angiogenesis by aminoacyl-tRNA synthetases.

Mirando AC, Francklyn CS, Lounsbury KM.

Int J Mol Sci. 2014 Dec 19;15(12):23725-48. doi: 10.3390/ijms151223725. Review.

11.

Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.

Novoa EM, Camacho N, Tor A, Wilkinson B, Moss S, Marín-García P, Azcárate IG, Bautista JM, Mirando AC, Francklyn CS, Varon S, Royo M, Cortés A, Ribas de Pouplana L.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5508-17. doi: 10.1073/pnas.1405994111. Epub 2014 Dec 8.

12.

Secreted Threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis.

Williams TF, Mirando AC, Wilkinson B, Francklyn CS, Lounsbury KM.

Sci Rep. 2013;3:1317. doi: 10.1038/srep01317.

13.

Substrate specificity and catalysis by the editing active site of Alanyl-tRNA synthetase from Escherichia coli.

Pasman Z, Robey-Bond S, Mirando AC, Smith GJ, Lague A, Francklyn CS.

Biochemistry. 2011 Mar 8;50(9):1474-82. doi: 10.1021/bi1013535. Epub 2011 Jan 31.

Supplemental Content

Loading ...
Support Center